Clinical trial
Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
NCT07261306 is registered in ClinicalTrials.gov with Lahore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
- Lead sponsor
- Lahore General Hospital
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- August 29, 2025
- Completion date
- December 25, 2025
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.